These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5015032)

  • 1. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV; Juengjaroen K; Michal F
    Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
    Baumgartner HR
    J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.
    Gordon JL; Olverman HJ
    Br J Pharmacol; 1978 Feb; 62(2):219-26. PubMed ID: 623937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of imipramine and some tryptamine derivatives on the efflux of 3H-5-hydroxytryptamine from rabbit platelets.
    Wölfel R; Graefe KH
    J Neural Transm Suppl; 1991; 34():77-83. PubMed ID: 1817167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
    Segonzac A; Tateishi T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
    Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of human platelet serotonin uptake by atypical histamine receptors.
    Launay JM; Bondoux D; Oset-Gasque MJ; Emami S; Mutel V; Haimart M; Gespach C
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R526-36. PubMed ID: 8141412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat.
    Connell LA; Wallis DI
    Br J Pharmacol; 1988 Aug; 94(4):1101-14. PubMed ID: 3207976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
    Wölfel R; Halbrügge T; Graefe KH
    Br J Pharmacol; 1989 Aug; 97(4):1308-14. PubMed ID: 2790384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antagonist of the 5-hydroxytryptamine receptor of blood platelets.
    Laubscher A; Pletscher A; Mester L; Mester M
    Arzneimittelforschung; 1982; 32(6):686-8. PubMed ID: 7202374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
    Wölfel R; Böhm W; Halbrügge T; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):1-8. PubMed ID: 3237251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
    Malmgren R
    Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different anticoagulants on human platelet size distribution and serotonin (5-HT) induced shape change and uptake kinetics.
    Malmgren R; Beving H; Olsson P
    Thromb Res; 1985 Jun; 38(6):649-61. PubMed ID: 3927509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.
    Laubscher A; Pletscher A; Noll H
    J Pharmacol Exp Ther; 1981 Feb; 216(2):385-9. PubMed ID: 6109775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.